The Effect of Tongfu Huayu Daotan Decoction on Concentrations of Serum S-100β, NSE and Prognosis in Patients with Severe Craniocerebrai Injury
- VernacularTitle:通腑化瘀导痰汤对重型颅脑损伤血清S-100β、NSE及预后的影响
- Author:
Jianlong HUANG
;
Yunhui LI
;
Zhongpin LIN
;
Weichao WU
;
Haibiao LAI
;
Weiqiang WU
;
Xiangming GU
;
Weiye LAI
- Publication Type:Journal Article
- Keywords:
Tongfu Huayu Daotan Decoction;
Craniocerebral injury;
Neuron specific enolase;
S- 100β protein;
Glasgow outcome scale
- From:
International Journal of Traditional Chinese Medicine
2008;30(5):326-327
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of Tongfu Huayu Daotan Decoction (通化阏导痰汤)on the serum concentration of S-100β protein, neuron-specific enolase(NSE) and Prognosis in patients with severe craniocerebral injury.Methods Sixty patients with severe craniocerebral injury were randomly divided into a a'eatment group and a control group.The treated group was treated with Tongfu Huayu Daotan Decoction plus conventional treatments including dehydration,antibiotics, organ functional support, nerve nutrition, prevention of complication, etc.; the control group was treated with conventional treatments alone. The concentration of serum S-100β protein and neuron-specific enolase(NSE) in plasma at admission and at24, 36, 72huors, and 5, 7 days after treatment were determined respectively; the Glasgow outcome scale (GOS)and neurological deficits scoring at 2weeks and 4weeks after hospitalization were compared to observe the efficacy of the patients. Results The concentration of serum S-100β protein and neuron-specific enolase (NSE) in plasma at previous treatment and at 24, 36 hours after the treatment had no statistical difference in the two groups(P＞0.05 ), The concentration of serum S-100β protein and neuron-specific enolase (NSE) in plasma at 72huors, 5 and 7 days after the treatment in the Tongfu Huayu Daotan Decoction group were lower than those in the control group, the differences being significant (P＜0.01). The Glasgow outcome scale (GOS) and neurological deficits scoring at 2weeks and 4weeks after the treatment in the Tongfu Huayu Daotan Decoction group were significantly nigher than those in the control group, the differences being significant (P＜0.01) .Conclusion Tongfu Huayu Daotan Decoction can alleviate the plasma concentrations of S-100β protein and neuron-specific enolase (NSE) in patients with severe craniocerebral injury and markedly improve the clinical therapeutic effects. Combined Tongfu Huayu Daotan Decoction and western medicine can significantly reduce mortality and improve the Glasgow outcome scale (GOS), neurological deficits scoring and therapeutic effect.
